The Influence of Cirrhosis on Steady-State Blood Concentrations of Unbound Propranolol after Oral Administration1

This publication has 16 references indexed in Scilit:

• Mechanism for reduced drug clearance in patients with cirrhosis
  Gastroenterology, 1978
• Biological determinants of propranolol disposition in man
  Clinical Pharmacology & Therapeutics, 1978
• Effects of liver disease on drug disposition in man
  Biochemical Pharmacology, 1976
• Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
  The Journal of Pharmacology and Experimental Therapeutics, 1975
• A physiological approach to hepatic drug clearance
  Clinical Pharmacology & Therapeutics, 1975
• Gas chromatographic assessment of the reproducibility of phenazone plasma half-life in young healthy volunteers
  European Journal of Clinical Pharmacology, 1974
• THE DISPOSITION OF PROPRANOLOL. III. DECREASED HALF-LIFE AND VOLUME OF DISTRIBUTION AS A RESULT OF PLASMA BINDING IN MAN, MONKEY, DOG AND RAT
  The Journal of Pharmacology and Experimental Therapeutics, 1973
• Plasma propranolol levels in adults With observations in four children
  Clinical Pharmacology & Therapeutics, 1970
• METABOLISM OF NIRIDAZOLE IN VARIOUS SPECIES, INCLUDING MAN
  Annals of the New York Academy of Sciences, 1969
• USE OF INDOCYANINE GREEN IN MEASUREMENT OF HEPATIC BLOOD FLOW AND AS A TEST OF HEPATIC FUNCTION
  1961